Toggle navigation
Home
Search
Services
Blog
Contact
About
Mechanism of Cyclin A-CDK2 Inhibition by P57
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Tinnitus Retraining Therapy Trial
The Cost Effectiveness of School-Based Supervised Asthma Therapy
Testing Sle Candidate Loci Using Cases & Their Parents
The Synthesis of Some Complex Cytotoxic Compounds
Core Facility - Molecular Spectroscopy
Recently added grants:
CD47 as a therapeutic target for obesity
PGI2 inhibition of pulmonary innate allergic immune responses
The role of Enterococcus faecalis in alcoholic liver disease
Neuronal exosomes to identify biomarkers and pathology of deployment-related TBI
Mechanisms of Berberine for the Treatment of Non-Alcoholic Fatty Liver Disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29GM055156-02
Application #
2899270
Study Section
Project Start
1998-08-03
Project End
1999-08-02
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Related projects
NIH 2001
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
Lumb, Kevin J. / Colorado State University-Fort Collins
$106,715
NIH 2000
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
Lumb, Kevin J. / Colorado State University-Fort Collins
$102,612
NIH 1999
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
Lumb, Kevin J. / Colorado State University-Fort Collins
NIH 1999
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
/
NIH 1998
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
Lumb, Kevin J. / Colorado State University-Fort Collins
NIH 1997
R29 GM
Mechanism of Cyclin A-CDK2 Inhibition by P57
Lumb, Kevin J. / Colorado State University-Fort Collins
Comments
Be the first to comment on this grant